Evobrutinib Active Not Recruiting Phase 3 Trials for Relapsing Multiple Sclerosis (RMS) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04338022Study of Evobrutinib in Participants With RMS (evolutionRMS 1)
NCT04338061Study of Evobrutinib in Participants With RMS (evolutionRMS 2)